Holen Sie sich die Stockscreener-App
3.595
10.85%
-0.475
Neonc Technologies Holdings Inc Aktie (NTHI) Neueste Nachrichten
NeOnc Technologies Holdings Secures $15 Million Registered Direct Offering After Positive Phase 2a Data and Insider Buying - quiverquant.com
NeOnc Raises $15 Million At Market Adding Fuel to the Strong NEO100 Data - marketscreener.com
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors - Stocktwits
NeOnc Technologies prices $15M registered direct offering - Investing.com
NeOnc Technologies prices $15M registered direct offering By Investing.com - Investing.com Canada
NeOnc Technologies Holdings, Inc. Announces Pricing of $15 - GlobeNewswire
Nearly half had no cancer progression at six months. NeOnc plans to meet U.S. drug regulators. - Stock Titan
NeOnc' Phase 2 Data Could Put Cancer on the Ropes - GlobeNewswire
NeOnc Technologies Holdings Reports Positive NEO100 Phase 2a Results and Prepares for FDA Registrational Pathway Discussion - quiverquant.com
NeOnc’s Phase 2A Success Could Set the Stage for Something Much Bigger - marketscreener.com
NeOnc’s brain cancer treatment beat its benchmark; it plans to ask the FDA what comes next - Stock Titan
NeOnc brain-cancer trial reports 48.9% progression-free at six months, vs. 20% benchmark - Stock Titan
Nature's Miracle Holding (NASDAQ:NTHI): What Could Its Scheduled Update Reveal? - Kalkine Media
NeOnc Technologies Holdings Founder Acquires 1.0% More Stock - Moomoo
ผู้ก่อตั้ง NeOnc Technologies Holdings เข้าซื้อหุ้นเพิ่มอีก 1.0% - Moomoo
NeOnc Technologies (NASDAQ: NTHI) names Shomali to audit panel - Stock Titan
Neonc Technologies CEO Thomas C. Chen acquires $70,010 of common shares via IRA - Bitget
NeOnc Technologies Holds 2026 Annual Stockholder Meeting - The Globe and Mail
Neonc Technologies CEO Thomas Chen buys $69,997 in stock - Investing.com
Neonc Technologies CSO Thomas Chen buys $192,899 in stock - Investing.com
Insider Purchase: CEO of $NTHI Buys 12,757 Shares - Moomoo
NeOnc Technologies (NTHI) CEO adds 12.8K-share IRA stake - Stock Titan
NeOnc Technologies (NTHI) investors approve equity plan, elect two directors - Stock Titan
Founder of NeOnc Technologies Holdings Thomas Chen Buys 1.0% More Shares - simplywall.st
Neonc Technologies CSO Thomas Chen buys $192,899 in stock By Investing.com - Investing.com Canada
NeOnc Technologies- Talk Is Cheap, Insider Buying Isn’t - Sahm
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock By Investing.com - Investing.com India
NeOnc Technologies (NTHI) CEO boosts stake with August open‑market buys - Stock Titan
Neonc Technologies CEO Amir Heshmatpour acquires $49,860 in stock - Investing.com
NeOnc (NTHI) CEO lifts direct stake to 3,096,000 shares - Stock Titan
NeOnc Technologies Holdings CEO Continues Open-Market Buying Following NEO100 Phase 2a Results and Elevated Short Interest - Quiver Quantitative
Neonc Technologies CEO buys $58,579 in company shares By Investing.com - Investing.com Australia
NTHI’s Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Sahm
Neonc Technologies CEO buys $58,579 in company shares - Investing.com
NeOnc Technologies (NTHI) CEO adds stock in two August buys - Stock Titan
NeOnc Technologies Holdings, Inc. Common Stock (NASDAQ: NTHI) Stock Price, News & Analysis - Kalkine
Duos Technologies Group Sets Second Quarter 2026 Earnings Call for Monday, August 17, 2026 at 4:30 PM ET - Stocktwits
NeOnc Technologies Holdings' Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Moomoo
NeOnc Technologies Holdings’ Phase 2a Results Strengthen the Case for Its Nasdaq-Backed Capital Strategy - Quiver Quantitative
NTHI's Nasdaq Advantage Takes on New Meaning After Its Breakthrough Phase 2a Results - Moomoo
NTHI: All proposals, including director elections and plan amendments, were approved without questions - TradingView
Maxim Group Maintains NeOnc Technologies(NTHI.US) With Buy Rating, Maintains Target Price $20 - Moomoo
The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech - The Manila Times
NeOnc Reports 26.1-Month Median Overall Survival in Phase 2a Brain Cancer Trial - Minichart
NeOnc Technologies holds investor call to discuss Phase 2a NEO100-01 results By Investing.com - Investing.com Nigeria
Form 8K Neonc Technologies Holdings Inc For: 13 August By Investing.com - Investing.com UK
NeOnc Technologies (NTHI) NEO100 Phase 2a Readout Clears Primary Endpoint, FDA Meeting Planned - kalkine.ca
NeOnc Technologies Holdings’ NEO100 Phase 2a Results Highlight Intranasal Brain-Delivery Platform Potential - Quiver Quantitative
NeOnc's Nasal Drug Delivery Strategy Reached a Brain-Cancer Trial - Stock Titan
NTHI Q1 2026 Earnings: Wider-than-Expected Loss Deepens as Shares Slide 3.32%Annual Report - vinanet.vn
Why is Neonc Technologies stock surging today? By Investing.com - Investing.com South Africa
Targeting The Mutant: NTHI’s NEO100 Data Could Open a New Front in the Fight Against Brain Cancer - The Manila Times
NeOnc Technologies Holdings Reports Positive Phase 2a Results for Intranasal NEO100 in Recurrent IDH1-Mutant High-Grade Glioma - Quiver Quantitative
NeOnc Technologies stock jumps on positive glioma trial data By Investing.com - Investing.com Australia
NeOnc Technologies shares jump after positive Phase 2a glioma results - Yahoo Finance
NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x - Yahoo Finance
Why is Neonc Technologies stock surging today? - Investing.com
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):